{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T21:53:42Z","timestamp":1720043622439},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T00:00:00Z","timestamp":1443484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.curtheres.2015.09.001","type":"journal-article","created":{"date-parts":[[2015,10,17]],"date-time":"2015-10-17T04:18:14Z","timestamp":1445055494000},"page":"99-105","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan\/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in China"],"prefix":"10.1016","volume":"90","author":[{"given":"Pingjin","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kezhi","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daifu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"L\u00fc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Licheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Pi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.curtheres.2015.09.001_bib0001","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: analysis of worldwide data","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.curtheres.2015.09.001_bib0002","first-page":"1148","article-title":"Current status of primary hypertension in China: an epidemiological study of 12 provinces, 1 autonomous region and 1 municipality","volume":"86","author":"Zhao","year":"2006","journal-title":"Chinese Medical Journal"},{"issue":"7","key":"10.1016\/j.curtheres.2015.09.001_bib0003","first-page":"579","article-title":"2010 Chinese guidelines for the management of hypertension","volume":"39","author":"Liu","year":"2011","journal-title":"Chinese Journal of Cardiology"},{"issue":"14","key":"10.1016\/j.curtheres.2015.09.001_bib0004","first-page":"74","article-title":"Antihypertensive drugs for patients with hypertension: combined therapy and individual treatment","volume":"7","author":"Xiao","year":"2009","journal-title":"Guide of China Medicine"},{"issue":"6","key":"10.1016\/j.curtheres.2015.09.001_bib0005","first-page":"9350936","article-title":"Analysis of application of antihypertensive drugs in a hospital from 2009 to 2011","volume":"19","author":"Han","year":"2012","journal-title":"Practical Preventive Medicine"},{"key":"10.1016\/j.curtheres.2015.09.001_bib0006","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/jhh.2008.153","article-title":"Efficacy and safety of initial combination therapy with amlodipine\/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study","volume":"23","author":"Flack","year":"2009","journal-title":"Journal of Human Hypertension"},{"issue":"10","key":"10.1016\/j.curtheres.2015.09.001_bib0007","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1524-6175.2007.06614.x","article-title":"Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy","volume":"9","author":"Drummond","year":"2009","journal-title":"The Journal of Clinical Hypertension"},{"issue":"2","key":"10.1016\/j.curtheres.2015.09.001_bib0008","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1742-1241.2008.01977.x","article-title":"The combination of amlodipine\/valsartan 5\/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg","volume":"63","author":"Schrader","year":"2009","journal-title":"The International Journal of Clinical Practices"},{"key":"10.1016\/j.curtheres.2015.09.001_bib0009","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension","volume":"31","author":"Mancia","year":"2013","journal-title":"Journal of Hypertension"},{"issue":"9","key":"10.1016\/j.curtheres.2015.09.001_bib00010","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1751-7176.2009.00159.x","article-title":"Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertension","volume":"11","author":"Chrysant","year":"2009","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"9","key":"10.1016\/j.curtheres.2015.09.001_bib00011","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.2165\/00003495-200262090-00005","article-title":"Olmesartan Medoxomil","volume":"62","author":"Warner","year":"2002","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.curtheres.2015.09.001_bib00012","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/00004872-200305002-00008","article-title":"Clinical efficacy of olmesartan medoxomil","volume":"21","author":"Brunner","year":"2003","journal-title":"J Hypertens Suppl"},{"issue":"3","key":"10.1016\/j.curtheres.2015.09.001_bib00013","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1524-6175.2007.06395.x","article-title":"Comparison of increasing doses of olmesartan medcxoniil. Losartan potassium, and valsartan in patients with essential hypertension","volume":"9","author":"Giles","year":"2007","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"1","key":"10.1016\/j.curtheres.2015.09.001_bib00014","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00129784-200505010-00006","article-title":"Use of 24-hour ambulatory blood pressure monitoring lo assess antihypertensive efficacy: a comparison of olmesartan medoxomil. Losartan potassium, valsartan, and irbesartan","volume":"5","author":"Smith","year":"2005","journal-title":"Am J Cardiovasc Drugs"},{"issue":"1","key":"10.1016\/j.curtheres.2015.09.001_bib00015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/0044011-200929010-00002","article-title":"Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study","volume":"29","author":"Volpe","year":"2009","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.curtheres.2015.09.001_bib00016","first-page":"25","article-title":"Efficacy and safety of olmesartan medoxomil\/amlodipine fixed-dose combination for hypertensive patients uncontrolled with monotherapy","author":"Zhu","year":"2014","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.curtheres.2015.09.001_bib00017","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.curtheres.2015.09.001_bib00018","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"Dahlof","year":"2005","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.curtheres.2015.09.001_bib00019","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00044011-200323070-00001","article-title":"Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil assessed by 24-hour ambulatory blood pressure monitoring in patients with essential hypertension","volume":"23","author":"Brunner","year":"2003","journal-title":"Clin Drug Invest"},{"issue":"5","key":"10.1016\/j.curtheres.2015.09.001_bib00020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1524-6175.2001.01136.x","article-title":"Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension","volume":"3","author":"Oparil","year":"2001","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"1","key":"10.1016\/j.curtheres.2015.09.001_bib00021","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00129784-200505010-00006","article-title":"Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan","volume":"5","author":"Smith","year":"2005","journal-title":"Am J Cardiovasc Drugs"},{"issue":"S1","key":"10.1016\/j.curtheres.2015.09.001_bib00022","doi-asserted-by":"crossref","first-page":"114A","DOI":"10.1016\/j.amjhyper.2004.03.298","article-title":"The combination of olmesartan medoxomil plus hydrochlorothiazide in subjects with stage 2 hypertension: Results of a randomized, double-blind, factorial-design study","volume":"17","author":"Kostis","year":"2004","journal-title":"Am J Hypertens."},{"issue":"6","key":"10.1016\/j.curtheres.2015.09.001_bib00023","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1751-7176.2011.00437.x","article-title":"A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil \u00b1 hydrochlorothiazide","volume":"13","author":"Weir","year":"2011","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"9","key":"10.1016\/j.curtheres.2015.09.001_bib00024","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.amjcard.2010.12.045","article-title":"Management of hypertension in patients with diabetes using an amlodipine-, olmesartan medoxomil-, and hydrochlorothiazide-based titration regimen","volume":"107","author":"Ram","year":"2011","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.curtheres.2015.09.001_bib00025","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/j.1552-4604.1991.tb03772.x","article-title":"A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide","volume":"31","author":"Elliott","year":"1991","journal-title":"J Clin Pharmacol."},{"key":"10.1016\/j.curtheres.2015.09.001_bib00026","doi-asserted-by":"crossref","DOI":"10.1111\/joim.12215","article-title":"Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses study","author":"Vandell","year":"2014","journal-title":"Journal of Internal Medicine"},{"issue":"11","key":"10.1016\/j.curtheres.2015.09.001_bib00027","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0895-7061(02)03000-5","article-title":"Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives","volume":"15","author":"Leonetti","year":"2002","journal-title":"American Journal of Hypertension"},{"issue":"5","key":"10.1016\/j.curtheres.2015.09.001_bib00028","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/01.HYP.0000067463.13172.EA","article-title":"Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension","volume":"41","author":"White","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.curtheres.2015.09.001_bib00029","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00044011-200929060-00002","article-title":"Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study","volume":"29","author":"Volpe","year":"2009","journal-title":"Clinical Drug Investigation"},{"key":"10.1016\/j.curtheres.2015.09.001_bib00030","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.clinthera.2010.07.008","article-title":"Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study","volume":"32","author":"Oparil","year":"2010","journal-title":"Clin Ther"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X15000120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X15000120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T04:18:10Z","timestamp":1564373890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X15000120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":30,"alternative-id":["S0011393X15000120"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2015.09.001","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan\/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in China","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2015.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}